Reports warn that some medicines used in people with heart conditions can increase the risk of diabetic ketoacidosis, a potentially life-threatening complication associated with diabetes. The concern focuses on drugs that affect blood sugar by changing how the body manages glucose.
Across coverage, the warning is framed around the possibility that treatment may lead to ketoacidosis, sometimes described in lay terms as a “diabetic attack.” Some outlets use alarm-focused language to highlight the severity and urgency of the risk, while also noting that ketoacidosis is a known medical complication linked to diabetes and related drug effects. The overall message in the reporting is to encourage awareness of symptoms and appropriate medical guidance when taking these therapies, particularly for patients who have diabetes or are at risk.
However, the sources provided do not specify which particular drug names, dosing details, patient eligibility criteria, or official issuing bodies for the warning. They also do not include quantified incidence rates or comparative risk estimates across populations.
